Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05270395 · ClinicalTrials.gov registry record · NA
Piloting 'mPal,' a Multilevel Strategy for Palliative Care Implementation
A NA study, sponsored by Laurie McLouth.
- Completed
- Registry status
- NA
- Development phase
- 75
- Enrollment target
NCT05270395: Completed NA study, sponsored by Laurie McLouth.
NCT05270395 is a NA study that has completed, run by Laurie McLouth. The registered enrollment target is 75 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05270395, a NA study, has completed, sponsored by Laurie McLouth.
- COMPLETED
- Registry status
- NA
- Development phase
- 75 participants
- Enrollment target
Study Summary
The purpose of this study is to assess the feasibility and acceptability of mPal, a multilevel implementation strategy to improve palliative care use among advanced stage lung cancer patients receiving cancer treatment.
Interventions
- BEHAVIORAL mPal
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 75 participants |
| Start Date | 2022-07-28 |
| Est. Completion | 2024-06-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05270395
The ClinicalTrials.gov registry entry for NCT05270395 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 75 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Laurie McLouth, which has 3 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which mPal is the first listed.
NCT05270395 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05270395 about?
NCT05270395 is a clinical study titled "Piloting 'mPal,' a Multilevel Strategy for Palliative Care Implementation". The purpose of this study is to assess the feasibility and acceptability of mPal, a multilevel implementation strategy to improve palliative care use among advanced stage lung cancer patients receiving cancer treatment.
What is the current status of trial NCT05270395?
This trial is currently completed. It is a NA study. The enrollment target is 75 participants. The study started on 2022-07-28. Estimated completion is 2024-06-01.
What interventions are being tested in trial NCT05270395?
The interventions under investigation include: mPal (BEHAVIORAL).
Who is sponsoring clinical trial NCT05270395?
This trial is sponsored by Laurie McLouth, which has 3 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.